Q4 2025 Holdings
Filed 2026-02-17 | 12 holdings | $330.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| CG Oncology, Inc.(CGON) | COM | 156944100 | $92.2M | 2,221,474 | 27.9% |
| Rapt Therapeutics, Inc.(RAPT) | COM | 75382E208 | $52.9M | 1,562,500 | 16.0% |
| Alumis Inc.(ALMS) | COM | 022307102 | $41.5M | 4,247,670 | 12.5% |
| Centessa Pharmaceuticals plc(CNTA) | SPONSORED ADS | 152309100 | $34.1M | 1,364,019 | 10.3% |
| Verastem, Inc.(VSTM) | COM | 92337C203 | $24.2M | 3,135,120 | 7.3% |
| Denali Therapeutics Inc.(DNLI) | COM | 24823R105 | $16.5M | 1,000,000 | 5.0% |
| Natera, Inc.(NTRA) | COM | 632307104 | $15.4M | 67,356 | 4.7% |
| Agios Pharmaceuticals, Inc.(AGIO) | COM | 00847X104 | $14.4M | 530,000 | 4.4% |
| Kymera Therapeutics, Inc.(KYMR) | COM | 501575104 | $11.4M | 146,332 | 3.4% |
| Atai Beckley N.V. | SHS | N0731H103 | $11.2M | 2,750,000 | 3.4% |
| Corvus Pharmaceuticals, Inc.(CRVS) | COM | 221015100 | $10.6M | 1,381,233 | 3.2% |
| Hinge Health, Inc.(HNGE) | CL A | 433313103 | $6.3M | 135,000 | 1.9% |